VMPL
Thiruvananthapuram (Kerala) [India], August 12: Dr. Ananthu S Manoj is an Indian physician, healthcare technology founder, and the Founder and Designated Partner of NeuroHue Therapeutics LLP, an Indian health technology company developing clinical intelligence systems for neurodevelopmental care.
NeuroHue was founded in 2025 by Dr. Ananthu S Manoj, following earlier work around structured developmental information and longitudinal clinical understanding. NeuroHue Therapeutics LLP was formally incorporated in India in 2026 and is headquartered in Thiruvananthapuram, Kerala.
The company is now extending its clinical technology work beyond India, with pilot activity and early clinical deployment in Malaysia, creating a cross-border environment in which its systems can be evaluated across different healthcare settings.
For Ananthu S Manoj, the expansion is also an opportunity to understand how structured clinical information behaves across populations, professional workflows and regional care environments.
Looking Beyond Individual Observations
Neurodevelopmental change is rarely represented by one dramatic event.
Small variations in response, behaviour, participation, engagement or consistency may appear insignificant individually but can become meaningful when examined across weeks or months.
"When a clinical judgement later proves incomplete, simply knowing that it needs to change is not enough," said Dr. Ananthu S Manoj. "We should be able to understand when the picture began changing, why it changed and what information may have been overlooked along the way."
NeuroHue is being developed around this longitudinal view of clinical information.
The company's technology focuses on organising clinical and behavioural observations into structured records and analytical views that can help professionals examine developmental change with greater continuity and context.
For Ananthu S Manoj, these accumulated micro-details represent an area where computational systems can complement human clinical reasoning.
"Human beings are exceptionally good at context and interpretation, but no individual can continuously retain and compare every small observation generated over long periods," he said. "That is where computation can become useful."
Clinical Intelligence, Not Automated Judgement
NeuroHue describes its approach as clinical intelligence rather than automated clinical decision-making.
Computational systems can organise large quantities of information, compare observations across time and surface relationships that might otherwise remain distributed across multiple encounters.
Dr. Ananthu S Manoj believes clinical judgement must remain with qualified professionals.
"Machines can organise, compare and process information," he said. "But clinical judgement should remain with the clinician. Healthcare also involves empathy, responsibility and human context."
The philosophy is therefore constructive rather than disruptive: technology should expand what clinicians can observe and understand without attempting to remove them from the care process.
"The revolutionary part should be what technology allows professionals to understand," said Dr. Ananthu S Manoj. "It does not need to be revolutionary because it removes the clinician."
Building the Foundations Beneath Artificial Intelligence
For Ananthu S Manoj, increasingly powerful artificial intelligence systems solve only one part of the healthcare intelligence problem.
The other part is the information beneath them.
"Before asking increasingly capable machines to understand healthcare, we first have to ask whether healthcare information itself has been represented properly," he said.
This has led NeuroHue towards work involving structured healthcare data, longitudinal clinical information, developmental measurement and clinical analytics, alongside research into machine learning methods that may eventually help professionals examine more complex relationships within healthcare information.
The company's developing presence across India and Malaysia adds another dimension to this work.
Clinical environments can differ across countries in population characteristics, languages, professional practices and patterns of care. For NeuroHue, working across these environments provides an opportunity to understand how clinical information systems can remain structured while accommodating regional context.
India, Malaysia and the Need for Regional Healthcare Data
Dr. Ananthu S Manoj believes the future of healthcare technology will depend not only on access to world-class computational models, but also on the quality and relevance of the information beneath those models.
India increasingly has access to sophisticated technologies developed globally. Yet many healthcare datasets and computational representations originate outside the populations in which future systems may ultimately be used.
"We should benefit from the best technologies developed anywhere in the world," said Ananthu S Manoj. "But India should not remain only a consumer of intelligence built on somebody else's foundation."
He believes India and other regional healthcare environments need stronger local clinical datasets that reflect their own populations, languages, behavioural patterns and systems of care.
NeuroHue's work in India and its emerging clinical activity in Malaysia is therefore being approached not simply as geographic expansion, but as part of a broader effort to understand clinical information across different regional environments.
The aim is not to isolate regional data from international science, but to build stronger local foundations capable of working alongside advances occurring globally.
Research and Intellectual Property
Alongside the development of its clinical intelligence systems, NeuroHue Therapeutics LLP has filed three patent applications in India relating to areas including neurodevelopmental assessment, therapy monitoring and data-driven clinical systems.
The intellectual property work reflects the company's broader interest in developmental measurement, structured longitudinal information and computational healthcare.
For Dr. Ananthu S Manoj, the long-term objective is to develop technology capable of working with increasingly detailed clinical information without transferring responsibility away from healthcare professionals.
From India Into Regional Clinical Environments
Work on the underlying clinical systems began before the formal establishment of the company.
NeuroHue was founded in 2025 by physician Dr. Ananthu S Manoj, bringing those ideas into a structured health technology initiative.
NeuroHue Therapeutics LLP was incorporated in India in 2026 and is headquartered in Thiruvananthapuram, Kerala.
The company is now expanding its technology across clinical environments in India while undertaking pilot activity and early clinical deployment in Malaysia, representing an early step in the organisation's development beyond its home market.
Its work sits at the intersection of clinical medicine, neurodevelopmental care, structured healthcare data and computational technology.
For Ananthu S Manoj, the longer-term opportunity is not a competition between clinicians and machines, nor simply the international expansion of another software platform.
"The better question is how we build systems where computation does what computation does well while preserving the parts of healthcare that remain fundamentally human," he said.
About Dr. Ananthu S Manoj
Dr. Ananthu S Manoj is an Indian physician and healthcare technology founder based in Kerala, India. He is the Founder and Designated Partner of NeuroHue Therapeutics LLP.
His work focuses on neurodevelopmental care, clinical intelligence, structured healthcare data, clinical analytics and machine learning research in healthcare.
Through NeuroHue Therapeutics, his work extends across clinical environments in India and Malaysia, alongside a broader interest in building healthcare technology and regional data foundations that reflect the populations and healthcare environments in which they are used.
Founder profile: AnanthuSManoj.com
About NeuroHue Therapeutics LLP
NeuroHue Therapeutics LLP is an Indian health technology company headquartered in Thiruvananthapuram, Kerala, India.
NeuroHue was founded in 2025 by physician Dr. Ananthu S Manoj, and NeuroHue Therapeutics LLP was formally incorporated in India in 2026.
The company develops clinical intelligence technology for neurodevelopmental care, with clinical activity across India and pilot activity and early clinical deployment in Malaysia.
NeuroHue Therapeutics has also filed three patent applications in India relating to neurodevelopmental assessment, therapy monitoring and data-driven clinical systems.
Website: NeuroHue.world
Media and institutional enquiries: contact@neurohue.world
(ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same.)
